View CNVs/SVs
View by Evidence Type: All (
CNVs Only Present In Patients
de novo CNVs
Overlapping/Recurrent CNVs
CNVs Overlapping With ACRD
CNVs Not Present In Control
Significant Enriched CNVs
Others
All
)
View by Chromosome:All ( 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X Y All )
Notes: ACRD: Autism Chromosome Rearrangement Database
CNV Name | Chr | Band | Gain/Loss | Number of CNVs | Evidence Type | Reference | |
---|---|---|---|---|---|---|---|
Case | Control | ||||||
AutCNV0005007 | 2 | 2q22.2 | gain | - | - | CNVs Only Present In Patients; | Al-Mamari W, 2015 |
AutCNV0005008 | 3 | 3p26.3 | gain | - | - | CNVs Only Present In Patients; | Al-Mamari W, 2015 |
AutCNV0005009 | 14 | 14q32.33 | loss | - | - | CNVs Only Present In Patients; | Al-Mamari W, 2015 |
AutCNV0005010 | X | Xp22.11 | gain | - | - | CNVs Only Present In Patients; | Al-Mamari W, 2015 |
AutCNV0005011 | 7 | 7q32.1q32.3 | loss | - | - | CNVs Only Present In Patients; | Al-Mamari W, 2015 |
AutCNV0005012 | X | Xp11.22 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Fieremans N, 2015 |
AutCNV0005013 | 3 | 3p26.1 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Liu Y, 2015 |
AutCNV0005014 | 1 | 1p31-q21 | - | - | - | CNVs Only Present In Patients; | Ruthsatz J, 2015 |
AutCNV0005015 | X | Xp22.13 | gain | - | - | CNVs Only Present In Patients; | Szafranski P, 2015 |
AutCNV0005016 | X | Xp22.13 | gain | - | - | CNVs Only Present In Patients; | Szafranski P, 2015 |
AutCNV0005017 | X | Xp22.13 | gain | - | - | CNVs Only Present In Patients; | Szafranski P, 2015 |
AutCNV0005018 | X | Xp22.13 | gain | - | - | CNVs Only Present In Patients; | Szafranski P, 2015 |
AutCNV0005019 | X | Xp22.13 | gain | - | - | CNVs Only Present In Patients; | Szafranski P, 2015 |
AutCNV0005020 | 2 | 2p16.3 | loss | - | - | CNVs Only Present In Patients; | Eriksson MA, 2015 |
AutCNV0005021 | 2 | 2p16.3 | loss | - | - | CNVs Only Present In Patients; | Eriksson MA, 2015 |
AutCNV0005022 | 2 | 2p16.3 | loss | - | - | CNVs Only Present In Patients; | Eriksson MA, 2015 |
AutCNV0005023 | 2 | 2q21.1 | loss | - | - | CNVs Only Present In Patients; | Eriksson MA, 2015 |
AutCNV0005024 | 7 | 7q35 | loss | - | - | CNVs Only Present In Patients; | Eriksson MA, 2015 |
AutCNV0005025 | 16 | 16p11.2 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Eriksson MA, 2015 |
AutCNV0005026 | 16 | 16p11.2 | loss | - | - | CNVs Only Present In Patients; | Eriksson MA, 2015 |
AutCNV0005027 | 16 | 16p11.2 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Eriksson MA, 2015 |
AutCNV0005028 | 16 | 16p11.2 | gain | - | - | CNVs Only Present In Patients; | Eriksson MA, 2015 |
AutCNV0005029 | 17 | 17p11.2 | gain | - | - | CNVs Only Present In Patients; de novo CNVs; | Eriksson MA, 2015 |
AutCNV0005030 | 17 | 17p13.3 | gain | - | - | CNVs Only Present In Patients; de novo CNVs; | Eriksson MA, 2015 |
AutCNV0005031 | 20 | 20p13.3 | gain | - | - | CNVs Only Present In Patients; de novo CNVs; | Eriksson MA, 2015 |